http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3743445-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a412b093994fe05351575adc15424e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_414fe0cac464bb7941e9be6a36574f25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf54fc76cc4cfd6b829c83379ef44897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f47c750954e13a1ed0be96c1bf1c51c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9327c3d08d0ca9f4f86d7569ad3b2ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_968c5f1d39a9f77e184f5faec3eb67c3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
filingDate 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f8bea82afb72e595dfaf66a491b111b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a2ffa8fc9800d7efb69004e275a5aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e504731c318f8cdd9f49546406d5b44b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b9a20b5cc352f162b1f63cc4f59efdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0c4a1328c7db9ed5ef8ca079b260081
publicationDate 2020-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3743445-A1
titleOfInvention Chimeric antigen receptors and methods for reducing off target toxicity
abstract Nucleic acid molecules that include a nucleotide sequence encoding a chimeric antigen receptor (CAR) and a nucleotide sequence encoding a protease sensitive scFv, wherein the chimeric antigen receptor comprises: an scFv targeting a tumor antigen, a spacer, a transmembrane domain, a co-stimulatory domain, and a CD3 ΞΆ signaling domain; and the protease-sensitive scFv and the scFv target the same tumor antigen are described.
priorityDate 2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383

Total number of triples: 52.